Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to -$227000.0.

  • Biomerica's Change in Receivables rose 87.34% to -$227000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$311000.0, marking a year-over-year decrease of 21780.3%. This contributed to the annual value of -$209000.0 for FY2025, which is 19720.93% down from last year.
  • Latest data reveals that Biomerica reported Change in Receivables of -$227000.0 as of Q4 2025, which was up 87.34% from $512000.0 recorded in Q3 2025.
  • In the past 5 years, Biomerica's Change in Receivables ranged from a high of $708000.0 in Q3 2023 and a low of -$777752.0 during Q3 2021
  • Its 5-year average for Change in Receivables is $24077.8, with a median of -$16992.5 in 2022.
  • Per our database at Business Quant, Biomerica's Change in Receivables plummeted by 420987.11% in 2021 and then surged by 168743.03% in 2023.
  • Quarter analysis of 5 years shows Biomerica's Change in Receivables stood at -$361698.0 in 2021, then skyrocketed by 115.76% to $57000.0 in 2022, then crashed by 749.12% to -$370000.0 in 2023, then soared by 38.11% to -$229000.0 in 2024, then grew by 0.87% to -$227000.0 in 2025.
  • Its Change in Receivables was -$227000.0 in Q4 2025, compared to $512000.0 in Q3 2025 and -$536000.0 in Q2 2025.